1
1. World Health Organization. World Heart Report. 2023. Report.
2
2. PERKENI. Pedoman pengelolaan dan pencegahan diabetes melitus tipe 2 dewasa di Indonesia. Edisi Pertama Jakarta: PB Perkeni. 2019.
3
3. Grundy SM, Stone NJ, Bailey AL, Beam C, Birtcher KK, Blumenthal RS, et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. Lippincott Williams and Wilkins; 2019. p. E1082–143. doi:10.1161/CIR.0000000000000625 PubMed PMID: 30586774.
4
4. Mahmood SS, Levy D, Vasan RS, Wang TJ. The Framingham Heart Study and the epidemiology of cardiovascular disease: A historical perspective. The Lancet. Elsevier B.V.; 2014. p. 999–1008. doi:10.1016/S0140-6736(13)61752-3 PubMed PMID: 24084292.
5
5. Fang YY, Huang CY, Hsu MC. Effectiveness of a physical activity program on weight, physical fitness, occupational stress, job satisfaction and quality of life of overweight employees in high-tech industries: a randomized controlled study. International Journal of Occupational Safety and Ergonomics. 2019 Oct 2;25(4):621–9. doi:10.1080/10803548.2018.1438839
6
6. Piché ME, Tchernof A, Després JP. Obesity phenotypes, metabolically healthy obesity, and cardiovascular disease risk. Annu Rev Nutr. 2022;42(1):21-44.
7
7. Pinheiro Tatiane Draguer Dal Ponte, Silva Brenda, Zanella Janice de Fátima Pavan, Salazar Rodrigo Fernando dos Santos, Bonfanti-Azzolin Gabriela. Cardiovascular disease risk among male workers of a regional electricity distribution company in Brazil. WORK. 2022 Oct 5;74(1):219–26. doi:10.3233/WOR-205238
8
8. PERKI. Panduan tata laksana dislipidemia. PB PERKI. 2017.
9
9. Zeng J, Lo CH. Editorial: Lipid metabolism dysregulation in obesity-related diseases and neurodegeneration. Vol. 16, Frontiers in Endocrinology. Frontiers Media SA; 2025.
10
10. Jiang H, Zhou Y, Nabavi SM, Sahebkar A, Little PJ, Xu S, et al. Mechanisms of Oxidized LDL-Mediated Endothelial Dysfunction and Its Consequences for the Development of Atherosclerosis. Frontiers in Cardiovascular Medicine. Frontiers Media S.A.; 2022. doi:10.3389/fcvm.2022.925923
11
11. Chen S, Cheng W. Relationship Between Lipid Profiles and Hypertension: A Cross-Sectional Study of 62,957 Chinese Adult Males. Front Public Health. 2022 May 18;10. doi:10.3389/fpubh.2022.895499 PubMed PMID: 35664125.
12
12. Andini FAD, Siregar AYM. Work hours and the risk of hypertension: the case of Indonesia. BMC Public Health. 2024 Dec 1;24(1). doi:10.1186/s12889-024-20003-z PubMed PMID: 39267069.
13
13. Fernández-Figares Vicioso MP, Riutord Sbert P, Ramírez-Manent JI, López-González ÁA, del Barrio Fernández JL, Vicente Herrero MT. Association Between Sociodemographic and Lifestyle Factors and Type 2 Diabetes Risk Scores in a Large Working Population: A Comparative Study Between the Commerce and Industry Sectors. Nutrients . 2025 Aug 1;17(15). doi:10.3390/nu17152420 PubMed PMID: 40806003.
14
14. Saltiel AR, Olefsky JM. Inflammatory mechanisms linking obesity and metabolic disease. Journal of Clinical Investigation. American Society for Clinical Investigation; 2017. p. 1–4. doi:10.1172/JCI92035 PubMed PMID: 28045402.
15
15. Piché ME, Tchernof A, Després JP. Obesity phenotypes, metabolically healthy obesity, and cardiovascular disease risk. Annu Rev Nutr. 2022;42(1):21–44.
16
16. Katsi V, Argyriou N, Fragoulis C, Tsioufis K. The Role of Non-HDL Cholesterol and Apolipoprotein B in Cardiovascular Disease: A Comprehensive Review. Vol. 12, Journal of Cardiovascular Development and Disease. Multidisciplinary Digital Publishing Institute (MDPI); 2025.
17
17. Nugraheni WP, Mubasyiroh R, Rachmawati T. Effects of the COVID-19 pandemic on cardiovascular disease financing in Indonesia (JKN claims data analysis 2019–2020) [Internet]. Jakarta; 2023 Mar. Available from:
https://icd.who.int/browse10/